/
/
/

Nath Bio-Genes (India) Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)132.00
Volume (₹)464.00
High (₹)134.00
Upper Circuit159.20
Low (₹)132.00
Lower Circuit106.14
Prev Close132.67
52W High (₹)204.00
Price132.27
52W Low (₹)126.15

Share Market Cap & Key Ratios Overview

M.Cap (₹)252.94 Cr
Div. Yield (%)1.50
PE Ratio6.91
Debt to Equity0.20
Price to Book0.36
Book Value358.06
EPS (TTM)19.26
Face Value10.00
ROE (%)6.28

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
KSCLNSE
VENKEYSNSE
AVTNPLNSE
FRESHARA-STNSE
REGAALNSE
BSHSLNSE
MGELNSE
SHEETAL-SMNSE
KOTYARKNSE
NATHBIOGENNSE
LTP
1W Low
1W High
Market cap (₹)
678.85+19.75 (3.00%)
650
682.15
3,441Cr
1581.1+76.8 (5.11%)
1491.20
1605.40
2,193Cr
98.22+10.38 (11.82%)
87.06
99.50
1,476Cr
398+22.5 (5.99%)
375.60
400
946Cr
86.48+0.16 (0.19%)
83.82
90.58
887Cr
83.6+0.42 (0.50%)
82.15
87.49
878Cr
17.24+0.24 (1.41%)
17
17.70
565Cr
384.9-4.85 (-1.24%)
365
392
469Cr
37.34-1.31 (-3.39%)
36
39.45
433Cr
132.27+1.26 (0.96%)
131.01
134.97
253Cr

Key Highlights of Nath Bio-Genes (India) Ltd Balance Sheet

Nath Bio-Genes (India) Ltd balance sheet discloses shareholders' funds of ₹19Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹19Cr, and the reserves and surplus of the company is ₹629.66Cr.

The company has its non-current liabilities with total liabilities of ₹1016.87Cr as of 2025-03-31.

The current liabilities are ₹363.05Cr as of 2025-03-31. At the same time, current assets are ₹680.55Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹6.05Cr and tangible assets of ₹250.22Cr, provided in the Nath Bio-Genes (India) Ltd financial statements.